LOW-DOSE INTERLEUKIN-2 (IL-2) EXPANDS NATURAL-KILLER (NK) CELL-POPULATIONS IN-VIVO BY SELECTIVE PREVENTION OF APOPTOSIS

被引：0
|
作者：
BLUMAN, EM
LINDEMANN, MJ
PORTER, MM
PIXLEY, L
FRANKEL, SR
CALIGIURI, MA
机构：
[1] ROSWELL PK CANC INST,DEPT MED,BUFFALO,NY
[2] ROSWELL PK CANC INST,DEPT MOLEC MED,BUFFALO,NY
[3] ROSWELL PK CANC INST,DEPT MOLEC IMMUNOL,BUFFALO,NY
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A288 / A288
页数：1
相关论文
共 50 条
  • [41] INVITRO RESTORATION BY INTERLEUKIN-2 (IL-2) OF THE IMPAIRED NATURAL-KILLER-CELL ACTIVITIES, IL-2 RECEPTOR EXPRESSION, AND T-CELL PROLIFERATION IN HEMOPHILIA
    ZAIZOV, R
    COHEN, IJ
    LURIA, D
    TRAININ, N
    UMIEL, T
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1986, 5 (04): : 339 - 350
  • [42] SELECTIVE MODULATION OF HUMAN NATURAL-KILLER-CELLS INVIVO AFTER PROLONGED INFUSION OF LOW-DOSE RECOMBINANT INTERLEUKIN-2
    CALIGIURI, MA
    MURRAY, C
    ROBERTSON, MJ
    WANG, E
    COCHRAN, K
    CAMERON, C
    SCHOW, P
    ROSS, ME
    KLUMPP, TR
    SOIFFER, RJ
    SMITH, KA
    RITZ, J
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01): : 123 - 132
  • [43] Subcutaneous IL-2 after autologous bmt expands nk in vivo but requires ex vivo high dose IL-2 for maximal activation.
    Miller, JS
    TessmerTuck, J
    Pierson, BA
    Weisdorf, D
    McGlave, P
    Blazar, B
    Katsanis, E
    Verfaille, C
    Burns, L
    BLOOD, 1996, 88 (10) : 2426 - 2426
  • [44] IN-VIVO TIME AND DOSE-DEPENDENCY OF INTERLEUKIN-6 SECRETION IN RESPONSE TO LOW-DOSE SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2
    MEFFERT, M
    HANNINEN, EL
    MENZEL, T
    SCHOMBURG, A
    DUENSING, S
    DALLMANN, I
    GROSSE, J
    VOCKE, S
    BUER, J
    DECKERT, M
    HILSE, R
    KIRCHNER, H
    POLIWODA, H
    ATZPODIEN, J
    CANCER BIOTHERAPY, 1994, 9 (04): : 307 - 316
  • [45] AUGMENTATION OF NATURAL-KILLER CELL-ACTIVITY AGAINST HUMAN RENAL-CARCINOMA CELL-LINE KU-2 BY RECOMBINANT HUMAN INTERLEUKIN-2 (IL-2)
    UENO, M
    MARUMO, K
    BABA, S
    MURAI, M
    YAMAMOTO, Y
    TAZAKI, H
    JOURNAL OF UROLOGY, 1986, 135 (04): : A302 - A302
  • [46] STIMULATION OF NATURAL-KILLER-CELLS IN ERYTHROLEUKEMIC INFANT MICE BY INTERLEUKIN-2(IL-2) +/- INDOMETHACIN
    DUSSAULT, I
    MILLER, SC
    FASEB JOURNAL, 1992, 6 (05): : A2052 - A2052
  • [47] Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancer
    Angevin, E
    ValteauCouanet, D
    Farace, F
    Dietrich, PY
    Lecesne, A
    Triebel, F
    Escudier, B
    JOURNAL OF IMMUNOTHERAPY, 1995, 18 (03): : 188 - 195
  • [48] NATURAL-KILLER (NK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) ACTIVATED KILLER (LAK) CELLS IN CANCER-PATIENTS
    CHING, N
    KUBOTA, I
    LOPEZ, M
    ANCHETA, A
    WONG, GK
    CHING, C
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (04) : 380 - 380
  • [49] The influence of interleukin-2 (IL-2), IL-7 and IL-15 on the development of natural killer cells.
    Craston, R
    Lowdell, MW
    Prentice, HG
    BLOOD, 1998, 92 (10) : 57B - 57B
  • [50] CELL-POPULATIONS IN THE HUMAN EARLY-PREGNANCY DECIDUA - NATURAL-KILLER ACTIVITY AND RESPONSE TO INTERLEUKIN-2 OF CD56-POSITIVE LARGE GRANULAR LYMPHOCYTES
    FERRY, BL
    STARKEY, PM
    SARGENT, IL
    WATT, GMO
    JACKSON, M
    REDMAN, CWG
    IMMUNOLOGY, 1990, 70 (04) : 446 - 452
12345